Pembrolizumab 200 mg Clinical Trials

1 actively recruiting trial

▼ -1 trial since June 2026

Also known as: Arm F, KEYTRUDA®, MK-3475

Pipeline

Phase 2: 1

Top Sponsors

Melanoma Institute Australia1

Indications

Mucosal Melanoma1
Cutaneous Melanoma1
Cancer1

Other1 trial

Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.